日本における再発性脳卒中に対するスタチン治療（J-STARS）

基本情報

NCT ID: NCT00221104
ステータス: 完了
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: 1,578
治験依頼者名: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

概要

Although hyperlipidemia is not always the risk factor of stroke, inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A(HMG-CoA) reductase can decrease the incidence of stroke in the patient with ischemic heart disease. The neuroprotective mechanism beyond cholesterol lowering should be expected to attenuate inflammation and atherosclerosis. The present study hypothesizes if pravastatin prevents recurrent stroke in the ischemic stroke patients with safety.

対象疾患

Ischemic Stroke

介入

Pravastatin(DRUG)

依頼者（Sponsor）

Ministry Of Health, Labour And Welfare, Japan(OTHER_GOV)

Translational Research Center For Medical Innovation, Kobe, Hyogo, Japan(OTHER)

Hiroshima University(OTHER)

実施施設 (1)

広島大学病院

Hiroshima, Japan